Purchases and Sales Made in Q1 2024 in Tyra Biosciences, Inc. (TYRA)
This table provides information about the institutional ownership of Tyra Biosciences, Inc. (TYRA) during Q1 2024. The information is specifically focused on institutions that hold shares of Tyra Biosciences, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 09, 2024
Q1 2024
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-334- 1.57% |
$3.88K - $6.68K
|
21K
$294K
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-431- 1.21% |
$5K - $8.62K
|
35.2K
$493K
|
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-431- 1.21% |
$5K - $8.62K
|
35.2K
$493K
|
|
|
May 15, 2024
Q1 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-860- 85.66% |
$9.98K - $17.2K
|
144
$2.02K
|
|
|
May 15, 2024
Q1 2024
|
California State Teachers Retirement System
West Sacramento, CA |
SELL
|
- |
-896- 38.92% |
$10.4K - $17.9K
|
1.41K
$19.7K
|
|
|
Apr 23, 2024
Q1 2024
|
Amalgamated Bank
New York, NY |
SELL
|
- |
-1.02K- 70.66% |
$11.9K - $20.4K
|
424
$5.94K
|
|
|
May 14, 2024
Q1 2024
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-1.36K- 65.56% |
$15.8K - $27.1K
|
713
$9.98K
|
|
|
Nov 05, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-1.6K- 83.31% |
$18.5K - $31.9K
|
320
$4.48K
|
|
|
May 03, 2024
Q1 2024
|
Victory Capital Management Inc
|
SELL
|
- |
-2.13K- 4.24% |
$24.7K - $42.6K
|
48.1K
$673K
|
|
|
May 15, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-3.92K- 92.46% |
$45.6K - $78.5K
|
320
$4.48K
|
|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-9.38K- 48.77% |
$109K - $188K
|
9.85K
$138K
|
|
|
May 15, 2024
Q1 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-10.4K- 34.53% |
$120K - $207K
|
19.6K
$275K
|
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-21.1K- 5.25% |
$245K - $422K
|
381K
$5.33M
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-29.3K- 45.4% |
$340K - $586K
|
35.2K
$493K
|
|
|
May 15, 2024
Q1 2024
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-47.7K- 98.96% |
$553K - $953K
|
501
$7.01K
|
|
|
May 15, 2024
Q1 2024
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
SELL
|
- |
-194K- 18.92% |
$2.25M - $3.88M
|
832K
$11.7M
|